Owlet Baby Care (OWLT) is at a new 3-year high, up 200% in the past year, with a 100% “Buy” rating from Barchart. Wall Street sees it as a “Strong Buy,” but Morningstar notes it’s currently overvalued by 10%. Valued at $250 million, Owlet provides a digital parenting platform for real-time data and insights. Their flagship product, the Dream Sock, uses pulse oximetry technology to monitor infant health. With a Weighted Alpha of +268.63, Owlet has maintained its Trend Seeker “Buy” signal and hit a 3-year high of $15.20. The stock gained 195.06% in the past year, with a 50-day moving average of $10.33. Revenue is projected to grow 33.97% this year. Wall Street analysts give Owlet a “Strong Buy” with price targets between $14.00 and $15.50. Morningstar believes the stock is overvalued by 10%, but investors on platforms like Motley Fool and Seeking Alpha are optimistic. Short interest is low at 1.82% of the float.

Read more at Yahoo Finance: Protect Your Babies and Your Portfolios with This ‘Strong Buy’ Stock